The treatment of severe malaria.
In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role...
主要な著者: | Dondorp, A, Day, N |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2007
|
類似資料
-
The management of patients with severe malaria.
著者:: Day, N, 等
出版事項: (2007) -
The treatment of severe malaria
著者:: Dondorp, A
出版事項: (2007) -
UK recommendations for severe malaria are worrying.
著者:: White, N, 等
出版事項: (2007) -
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
著者:: Dondorp, A, 等
出版事項: (2005) -
Malaria treatment in the United States.
著者:: Hanson, J, 等
出版事項: (2007)